| OCR Text |
Show 56 LITERATURE ABSTRACTS Czarnecki's Sign as the Initial Finding in Acquired Ocu.lomotor Synkinesis. CoxTA. Am J Ophtlzalinol 1986;102:543 (Oct). [Reprinfrequests to Terry A Cox; M.D" Department ofOphthalmology, University of British Columbia, 2550, Willow St., Vancouver, ,British Columbia/Canada V5Z 3N9.] '.::. ·.These pape~se~ch desciib~ onepatierif\¥ith';i' traumatic third nerve lesion who exhibited seg-.· mental contracture of the iris sphincter,in one" with down-gaze and in the others spontaneously. Neither pupil reacted to light and,in the first case, classic signs6f aberrant regeneration developed after the pupiLabnormality was documented,'In both,cases"DLCoximplicates neuroI1sinthe cil- .. iarY'gangliolrasgenerating the impulseto con~ traction,although the exact mechanismpostulated . differs in each case. SpontaneousC:ontraCtiorisof'thePupillary Sphinderil1Traumatic Ophthalm()plegia:Cox .' '.' TA. Am ]OphthalmoI1986;102:543-,-,4(Oct);[Re- , . 'ptirit requests to TerryA.Cox, M. 0" Department ,0fOphthalrriology,Uhiversity of. BritishCo-' lumbia, 2550 Willow St.;Vancouver, British Co-lumbia, Canada V5Z 3N9.]· Hyperbaric Oxygen in the Treatment of Radia-' tion-inducedOptic Neuropathy. Guy J,Schatz NJOplztlzalmologyJ986; 93:1083-8 (Aug). [Reprint requests to John Guy, M,D., Neuro-Ophthalmology Service, JHMHC Box J-284, UnivefsityofFlorida, College of Medicine, Gainesville"FL3261O.] .. Four patieritswith presumed radiation~iriduted :optic neuropathy who were treated With hyper- .. baric oxygen are presented. Radiationtherapyhad./ . been given previously for a pituitarytllmor in two patients and forretic-ulum cell sarcomaandme~ ningibma in one patient 'each. One patient with unilateral decreased vision had >a virtual "cure" after 14 treatments; anotherhadrriarked improvementafter 14 treatmerttsbutrelapsed and did nbi' resportdto further sessions, The other two pa~ . .tients were probably treated too late after onset of optic neuropathy for good effect:',Theseal1thors .. 'acknowledge that spontane'ous remission can occur inthis disease but believe that the two pa~ tients who were quickly recognized and treated had'i~provementthat can be attributed to the hyperbaric uxygeritreatment itself. They recommend hyperbaric oxygen emergently if visual loss has occurred within2 weeks and continued therapy of 14 sessiorisaftervisualacuity has improved and stabilized. .. . .Lyn A.'Sedl!Jick;M.O. /,' ./ - . - .-. __.---.- .- _.' / .," .' LYnA. Sedlbick;M.O. ,Treatinent·of Facial Sl'~snl~th6culimun(C.b;t.' ulintl1ntoxin) .•• BiglanAW,MayM.] Pediatr. Oph..' thalmol Stfabisl1lUs .1986;23:216-221 (Sept/Oct): [Re-print requests to Albert W.. Biglan, M.D., 3518 -FifthAvenue, Pittsburgh, PA 15213] PolyaiteritisNodosa Diagrtosedby TemporalArterYBiopsy. Coppeto]R, Miller 0 .Am •J Oplz-' fhalmol 1986;102:541 (Oct):jReprinfrequests to James KCoppeto, M.D.,J906N-Main St., Waterbury,' CT 06704,] ·.A· 76~year~oldwomanwith a'sedimentatiOnrate of 115 mm/hr(Westergren) had transierttlbss of vision'in her right eye and headaches. Aterriporal .-This is Ont>of many 'recently published articles arterybiofYsydisclosed a subacute granulomatous discussing the merits of botulinum toxioin the reaction without giant cells, some activeinflam- treatment dffacial spasm. Unfortunately; at the mation, and fibrinoid necrosis. This biOpsy was time this is written, botulinum toxin is no longer thought to be consistent with the diagnosis of, available for Clinical use. The cOIhpanythat com-polyarteritis nboosa, and further pathologic spec:':' ,mercially prepares the toxin is unable to obtain ad~ imens from the patient's bowel likewise showed equate liability insurance. For many patients inca- ,. evidence of fhisdisease. The authors underscore .- pacitated by facial spasm, botulirmmtoxin is . that, although the literature does not stress the.' ,cleadythe treatment 'of choice, Let uSh6pe that use of lemporalartery biopsy in diagrt6singthis' .thisundesirablesituatioIi is quickly resolved so disorder, such a biopsy is often as helpful iri diag- that our patients may benefit from this valuable HosingpoJyarteritis nodosa as giant cellarteiitis. . new treatment. .Scdwitk, M.O: Walter M. Jay, M,D. . LITERATURE ABSTRACTS 57 Editorial Note (November 18, 1986): Dr. Alan B. Scott, the originator of oculinum therapy in ophthalmology, has just saved the day by having the production of this important medication resumed. I understand that supplies are rapidly becoming available again to those investigators who have used it in the past. Hopefully, the above note by Dr. Jay should be past history by the time this abstract is in printl ]. L. Smith, M.D. JCli" Nellrr-rl'hth"II11(1/, Vol. 7, No.1, 1987 |
